参芪通脉颗粒治疗慢性充血性心力衰竭44例  

Forty-Four Cases with Chronic Congestive Heart Failure Treated with Shenqi Tongmai Granules

作　　者：汶医宁[1] 史凡凡[1] 罗文平[1] 李瑞[1] 王永刚[2] 

机构地区：[1]陕西中医药大学附属医院,陕西咸阳712000 [2]陕西中医药大学第二附属医院,陕西咸阳712000

出　　处：《河南中医》2016年第1期55-56,共2页Henan Traditional Chinese Medicine

摘　　要：目的:观察参芪通脉颗粒治疗慢性充血性心力衰竭的临床疗效。方法:选取2011年1月—2013年12月在本院住院的慢性充血性心力衰竭患者86例,随机分为治疗组44例和对照组42例。对照组给予常规对症治疗,治疗组在对照组的基础上给予参芪通脉颗粒。结果:治疗组有效率90.9%,对照组效率78.6%,治疗组优于对照组(P<0.05);治疗组治疗后左心室舒张末期内径(LVEDD)、左室射血分数(LVEF)、E/A值均优于对照组(P<0.05);两组治疗后BNP浓度显著降低,两组间比较差异无统计学意义(P>0.05)。结论:参芪通脉颗粒治疗慢性充血性心力衰竭疗效显著。Objective： To observe the clinical effects of Shenqi Tongmai Granules on chronic congestive heart failure（ CCHF）.Methods： 86 patients with CCHF hospitalized in this hospital between January,2011 and December,2013 were randomly divided into treatment group（ 44 cases） and control group（ 42 cases）. Control group were given regular symptomatic treatment while treatment group were added with Shenqi Tongmai Granules. Results： The effective rate was 90. 9% in treatment group,higher than78. 6% in control group（ P 〈 0. 05）. The values of LVEDD,LVEF and E/A in treatment group were all better than these in control group after the treatment（ P 〈 0. 05）. The density of BNP in both groups got markedly decline but there was no significant difference between the two groups（ P 〉 0. 05）. Conclusion： Shenqi Tongmai Granules have remarkable therapeutic effects on CCHF.

关 键 词：慢性充血性心力衰竭 参芪通脉颗粒 左心室舒张末期内径 左室射血分数 

分 类 号：R259.416.1[医药卫生—中西医结合]